NCT05803018View on ClinicalTrials.gov

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 25, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Gynecological Malignant TumorSolid Tumor
Interventions
DRUG

BL-B01D1

Administration by intravenous infusion

Trial Locations (1)

Unknown

RECRUITING

Fudan University ShangHai Cancer Center, Shanghai

All Listed Sponsors
collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY